BDBM273349 US10071079, Example 128::US10478424, Example 128

SMILES: CC(C)c1c([nH]c2ccc(cc12)C1CCNCC1)-c1cc(c2ncnn2c1)C(F)(F)F

InChI Key: InChIKey=DIURQNKKHJIVSO-UHFFFAOYSA-N

Data: 6 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 273349   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Toll-like receptor 7 (Homo sapiens (Human))	BDBM273349 (US10071079, Example 128 | US10478424, Example 128) Show SMILES CC(C)c1c([nH]c2ccc(cc12)C1CCNCC1)-c1cc(c2ncnn2c1)C(F)(F)F Show InChI InChI=1S/C23H24F3N5/c1-13(2)20-17-9-15(14-5-7-27-8-6-14)3-4-19(17)30-21(20)16-10-18(23(24,25)26)22-28-12-29-31(22)11-16/h3-4,9-14,27,30H,5-8H2,1-2H3	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.400	n/a	n/a	n/a	n/a	n/a	25
Bristol-Myers Squibb Company US Patent					Assay Description HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...				US Patent US10071079 (2018) BindingDB Entry DOI: 10.7270/Q2VD71GV
					More data for this Ligand-Target Pair
Toll-like receptor 8 (Homo sapiens (Human))	BDBM273349 (US10071079, Example 128 | US10478424, Example 128) Show SMILES CC(C)c1c([nH]c2ccc(cc12)C1CCNCC1)-c1cc(c2ncnn2c1)C(F)(F)F Show InChI InChI=1S/C23H24F3N5/c1-13(2)20-17-9-15(14-5-7-27-8-6-14)3-4-19(17)30-21(20)16-10-18(23(24,25)26)22-28-12-29-31(22)11-16/h3-4,9-14,27,30H,5-8H2,1-2H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	12.1	n/a	n/a	n/a	n/a	n/a	25
Bristol-Myers Squibb Company US Patent					Assay Description HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...				US Patent US10071079 (2018) BindingDB Entry DOI: 10.7270/Q2VD71GV
					More data for this Ligand-Target Pair
Toll-like receptor 9 (Homo sapiens (Human))	BDBM273349 (US10071079, Example 128 | US10478424, Example 128) Show SMILES CC(C)c1c([nH]c2ccc(cc12)C1CCNCC1)-c1cc(c2ncnn2c1)C(F)(F)F Show InChI InChI=1S/C23H24F3N5/c1-13(2)20-17-9-15(14-5-7-27-8-6-14)3-4-19(17)30-21(20)16-10-18(23(24,25)26)22-28-12-29-31(22)11-16/h3-4,9-14,27,30H,5-8H2,1-2H3	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.65E+3	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...				US Patent US10478424 (2019) BindingDB Entry DOI: 10.7270/Q2QZ2DB0
					More data for this Ligand-Target Pair
Toll-like receptor 7 (Homo sapiens (Human))	BDBM273349 (US10071079, Example 128 | US10478424, Example 128) Show SMILES CC(C)c1c([nH]c2ccc(cc12)C1CCNCC1)-c1cc(c2ncnn2c1)C(F)(F)F Show InChI InChI=1S/C23H24F3N5/c1-13(2)20-17-9-15(14-5-7-27-8-6-14)3-4-19(17)30-21(20)16-10-18(23(24,25)26)22-28-12-29-31(22)11-16/h3-4,9-14,27,30H,5-8H2,1-2H3	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.400	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...				US Patent US10478424 (2019) BindingDB Entry DOI: 10.7270/Q2QZ2DB0
					More data for this Ligand-Target Pair
Toll-like receptor 8 (Homo sapiens (Human))	BDBM273349 (US10071079, Example 128 | US10478424, Example 128) Show SMILES CC(C)c1c([nH]c2ccc(cc12)C1CCNCC1)-c1cc(c2ncnn2c1)C(F)(F)F Show InChI InChI=1S/C23H24F3N5/c1-13(2)20-17-9-15(14-5-7-27-8-6-14)3-4-19(17)30-21(20)16-10-18(23(24,25)26)22-28-12-29-31(22)11-16/h3-4,9-14,27,30H,5-8H2,1-2H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	12.1	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...				US Patent US10478424 (2019) BindingDB Entry DOI: 10.7270/Q2QZ2DB0
					More data for this Ligand-Target Pair
Toll-like receptor 9 (Homo sapiens (Human))	BDBM273349 (US10071079, Example 128 | US10478424, Example 128) Show SMILES CC(C)c1c([nH]c2ccc(cc12)C1CCNCC1)-c1cc(c2ncnn2c1)C(F)(F)F Show InChI InChI=1S/C23H24F3N5/c1-13(2)20-17-9-15(14-5-7-27-8-6-14)3-4-19(17)30-21(20)16-10-18(23(24,25)26)22-28-12-29-31(22)11-16/h3-4,9-14,27,30H,5-8H2,1-2H3	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.65E+3	n/a	n/a	n/a	n/a	n/a	25
Bristol-Myers Squibb Company US Patent					Assay Description HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...				US Patent US10071079 (2018) BindingDB Entry DOI: 10.7270/Q2VD71GV
					More data for this Ligand-Target Pair